Turnstone Biologics Corp
NASDAQ:TSBX
Balance Sheet
Balance Sheet Decomposition
Turnstone Biologics Corp
Turnstone Biologics Corp
Balance Sheet
Turnstone Biologics Corp
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
123
|
35
|
18
|
29
|
|
| Cash Equivalents |
123
|
35
|
18
|
29
|
|
| Short-Term Investments |
38
|
47
|
77
|
0
|
|
| Total Receivables |
7
|
9
|
0
|
0
|
|
| Accounts Receivables |
7
|
9
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
10
|
7
|
8
|
5
|
|
| Total Current Assets |
177
|
98
|
103
|
34
|
|
| PP&E Net |
9
|
14
|
9
|
5
|
|
| PP&E Gross |
9
|
14
|
9
|
5
|
|
| Accumulated Depreciation |
3
|
6
|
7
|
8
|
|
| Other Long-Term Assets |
1
|
3
|
1
|
1
|
|
| Total Assets |
187
N/A
|
115
-39%
|
113
-2%
|
40
-64%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
3
|
0
|
1
|
|
| Accrued Liabilities |
21
|
16
|
12
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
34
|
15
|
0
|
1
|
|
| Total Current Liabilities |
55
|
35
|
12
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Liabilities |
42
|
10
|
2
|
0
|
|
| Total Liabilities |
97
N/A
|
44
-54%
|
14
-68%
|
9
-39%
|
|
| Equity | |||||
| Common Stock |
172
|
172
|
0
|
0
|
|
| Retained Earnings |
91
|
122
|
177
|
248
|
|
| Additional Paid In Capital |
9
|
21
|
276
|
279
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
90
N/A
|
70
-22%
|
99
+40%
|
31
-68%
|
|
| Total Liabilities & Equity |
187
N/A
|
115
-39%
|
113
-2%
|
40
-64%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
22
|
22
|
148
|
23
|
|